These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18439732)
1. The epidemiology of mumps in Italy. Gabutti G; Guido M; Rota MC; De Donno A; Ciofi Degli Atti ML; Crovari P; Vaccine; 2008 Jun; 26(23):2906-11. PubMed ID: 18439732 [TBL] [Abstract][Full Text] [Related]
2. Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence. Janaszek-Seydlitz W; Bucholc B; Gorska P; Slusarczyk J Vaccine; 2005 Apr; 23(21):2711-6. PubMed ID: 15780717 [TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of mumps, varicella and rubella antibodies in children 1-16 years of age in eastern Turkey. Gürgöze MK; Yilmaz E; Gödekmerdan A; Akça Z; Doğan Y; Akarsu S; Aygün AD Turk J Pediatr; 2006; 48(3):185-8. PubMed ID: 17172059 [TBL] [Abstract][Full Text] [Related]
4. [Rubella epidemiology in Italy in years 1998-2004]. Giambi C; Rota MC; Bella A; Filia A; Gabutti G; Guido M; De Donno A; Ciofi degli Atti ML Ann Ig; 2007; 19(2):93-102. PubMed ID: 17547214 [TBL] [Abstract][Full Text] [Related]
5. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey]. Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073 [TBL] [Abstract][Full Text] [Related]
6. Age-specific mumps seroprevalence of an unvaccinated population of adolescents in Ankara, Turkey. Kanbur NO; Derman O; Kutluk T Jpn J Infect Dis; 2003; 56(5-6):213-5. PubMed ID: 14695433 [TBL] [Abstract][Full Text] [Related]
7. [Serological determination of anti-mumps immunity in a population sample from Palermo]. Pistoia D; Di Stefano R; Arista S; Ammatuna P Boll Ist Sieroter Milan; 1991-1992; 70(1-2):483-5. PubMed ID: 1670051 [TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization. Avijgan M; Habibian R; Kheiri S East Mediterr Health J; 2009; 15(2):295-301. PubMed ID: 19554975 [TBL] [Abstract][Full Text] [Related]
9. Seroepidemiology of the recent mumps virus outbreaks in Ireland. Hassan J; Dean J; Moss E; Carr MJ; Hall WW; Connell J J Clin Virol; 2012 Apr; 53(4):320-4. PubMed ID: 22269391 [TBL] [Abstract][Full Text] [Related]
10. Measles serological survey in the Italian population: interpretation of results using mixture model. Rota MC; Massari M; Gabutti G; Guido M; De Donno A; Ciofi degli Atti ML Vaccine; 2008 Aug; 26(34):4403-9. PubMed ID: 18585420 [TBL] [Abstract][Full Text] [Related]
11. Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy. Levine H; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Zarka S; Balicer RD Vaccine; 2011 Mar; 29(15):2785-90. PubMed ID: 21320550 [TBL] [Abstract][Full Text] [Related]
12. Sero-prevalence of mumps antibodies in subpopulations subsequently affected by a large scale mumps epidemic in Israel. Muhsen K; Shohat T; Aboudy Y; Mendelson E; Algor N; Anis E; Cohen D Vaccine; 2011 May; 29(22):3878-82. PubMed ID: 21453788 [TBL] [Abstract][Full Text] [Related]
13. Preventable infectious diseases using vaccination in developmental age in the province of Frosinone, Italy. Langiano E; Lanni L; Ferrara M; Atrei P; Martellucci G; De Vito E J Prev Med Hyg; 2007 Sep; 48(3):97-102. PubMed ID: 18274346 [TBL] [Abstract][Full Text] [Related]
14. Mumps seroprevalence in an unvaccinated population in Izmir, Turkey. Aksit S; Egemen A; Ozacar T; Kurugol Z Acta Paediatr; 2000 Mar; 89(3):370-1. PubMed ID: 10772294 [No Abstract] [Full Text] [Related]
15. [Mumps in Poland in 2004]. Stefanoff P Przegl Epidemiol; 2006; 60(3):389-92. PubMed ID: 17249158 [TBL] [Abstract][Full Text] [Related]
16. [Epidemic parotitis: etiology, epidemiology and prevention]. Crovari P G Mal Infett Parassit; 1969 Jun; 21(5):337-48. PubMed ID: 5364694 [No Abstract] [Full Text] [Related]
17. [Susceptibility to varicella-zoster, measles, rosacea and mumps among health care workers in a Northern Italy hospital]. Porru S; Campagna M; Arici C; Carta A; Placidi D; Crotti A; Parrinello G; Alessio L G Ital Med Lav Ergon; 2007; 29(3 Suppl):407-9. PubMed ID: 18409748 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease. Muhsen Kh; Aboudy Y; Mendelson E; Green MS; Cohen D Epidemiol Infect; 2008 May; 136(5):688-93. PubMed ID: 17608960 [TBL] [Abstract][Full Text] [Related]
19. Mumps resurgence prompts revised recommendations. Miller C Minn Med; 2007 Feb; 90(2):41-3. PubMed ID: 17388260 [TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence study of parvovirus B19 in Poland]. Siennicka J; Stefanoff P; Trzcińska A; Rosińska M; Litwińska B Przegl Epidemiol; 2006; 60(3):571-80. PubMed ID: 17249182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]